Granules India Discloses Preferential Warrant Allotment

Granules India has formalized the allotment of 2,50,00,000 warrants at an issue price of Rs 585 each. The transaction involves a 25% upfront payment of Rs 146.25 per warrant, with the remainder payable upon conversion into equity shares.

Reader Takeaway: Promoters solidify ownership through warrant infusion while future dilution remains dependent on 18-month conversion timelines.

What Just Happened

The company allotted 2,49,82,906 warrants to the promoter group, specifically Mrs. Chigurupati Uma Devi, Mrs. Priyanka Chigurupati, Mrs. Pragnya Chigurupati, and Mr. Harsha Chigurupati. An additional 17,094 warrants were issued to a non-promoter investor. These securities were issued on February 23, 2026, with the BSE filing disclosure arriving in October 2026.

Why This Matters

For investors, this represents a capital infusion strategy. The promoter group, which held a 38.82% stake prior to the allotment, is effectively increasing its commitment to the company. The warrants are convertible into equity shares of Rs 1 each within a window of eighteen months.

Shareholding and Dilution

The company has also reported the separate allotment of 51,28,205 equity shares to non-promoter investors. Following these actions, the post-allotment equity share capital stands at Rs 24,77,96,921. The total diluted share capital, which accounts for the full conversion of the 2.5 crore warrants, is projected at 27,27,96,921 shares.

What to Track Next

Investors should monitor the conversion status of these warrants over the coming months. As these instruments are exercised, the share capital will increase, which will impact earnings per share calculations. The alignment of the promoters with the issuance price suggests confidence in the company's long-term valuation, but shareholders must account for the potential equity dilution as the 18-month conversion period progresses.